Objective: To provide a teratology update for prescription and non-prescription drugs and infections during pregnancy.
Options: Limited to teratology principles and possible common exposures during pregnancy.
Evidence: A search of Medline and textbooks was conducted for information published to June 2006 on teratology exposure risks. This document represents an abstraction of the information.
Benefits, harms, and costs: This consensus provides practitioners with a summary of information regarding teratology risks for drug, chemical, and infection exposures during pregnancy.